Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Other Operating Expenses (2016)

vTv Therapeutics' Other Operating Expenses history spans 3 years, with the latest figure at $529000.0 for Q3 2016.

  • For Q3 2016, Other Operating Expenses fell 9.73% year-over-year to $529000.0; the TTM value through Jun 2017 reached $529000.0, down 68.27%, while the annual FY2016 figure was $795000.0, 66.13% down from the prior year.
  • Other Operating Expenses for Q3 2016 was $529000.0 at vTv Therapeutics, up from $72000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $815000.0 in Q4 2015 and bottomed at $72000.0 in Q2 2016.
  • The 3-year median for Other Operating Expenses is $391000.0 (2015), against an average of $414111.1.
  • The largest annual shift saw Other Operating Expenses soared 178.16% in 2015 before it plummeted 87.05% in 2016.
  • A 3-year view of Other Operating Expenses shows it stood at $293000.0 in 2014, then skyrocketed by 178.16% to $815000.0 in 2015, then crashed by 35.09% to $529000.0 in 2016.
  • Per Business Quant, the three most recent readings for VTVT's Other Operating Expenses are $529000.0 (Q3 2016), $72000.0 (Q2 2016), and $194000.0 (Q1 2016).